Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review

In May 2016, countries using oral polio vaccine for routine immunization switched from trivalent oral poliovirus vaccine (tOPV) to bivalent type 1 and 3 OPV (bOPV). This was done in order to reduce risks from type 2 vaccine-derived polioviruses (VDPV2) and vaccine-associated paralytic poliomyelitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandyopadhyay, Ananda S, Modlin, John F, Wenger, Jay, Gast, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206125/
https://www.ncbi.nlm.nih.gov/pubmed/30376081
http://dx.doi.org/10.1093/cid/ciy633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206125/
https://www.ncbi.nlm.nih.gov/pubmed/30376081
http://dx.doi.org/10.1093/cid/ciy633

Ejemplares similares